<DOC>
	<DOCNO>NCT00427986</DOCNO>
	<brief_summary>The purpose present study examine , retinal swell diabetic patient reduce intravenous injection galactose .</brief_summary>
	<brief_title>Clinical Study Effect Intravenous Galactose Diabetic Macular Oedema</brief_title>
	<detailed_description>Macular oedema ( swell retina ) lead cause severe visual loss blindness patient diabetes . The oedema cause fluid accumulation retinal tissue leak capillary lead increase retinal thickness . Optical Coherence Tomography ( OCT ) become primary technique estimate retinal thickness objectively , scan perform without discomfort patient dilation pupil . According Starling equation , general basic physiologic rule , specific factor influence fluid transport capillary surround tissue . One factor balance large molecule within vessel lumen surround tissue , e.g . osmotic pressure balance . By change osmotic balance drug reduce fluid content tissue extract water tissue vessel lumen . Such drug galactose . In present study examine , treatment intravenous galactose reduce retinal thickness diabetic macular oedema evaluate OCT three-hour monitoring . Galactose ( 0.5 mg/mL ) administer 1 mL galactose per kg body weight + 10 % maximum 80 mL , injection time 5 min . If reduction thickness galactose find , confirm application Starling osmotic force diabetic macular oedema . In time span series venous blood sample take analysis plasma osmolarity electrolytes . The systemic blood pressure also monitor well capillary glucose level . As diurnal variation retinal thickness estimate potentially influence result , OCT measurement blood sample repeat second day participant , without treatment galactose comparison . The order two visit give randomisation . Interim analysis take place inclusion 15 20 patient evaluate need inclusion 45 patient .</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<criteria>Type 1 type 2 diabetes clinically significant macular oedema visual acuity minimum 40 letter ETDRS procedure retinal thickness least 250 micron foveal region three retinal map fast protocol StratusOCT baseline least 300 micron outside foveal region 1 disc area oedema within 3000 micron foveal center three retinal map fast protocol StratusOCT baseline maximal blood pressure 160/90 mmHg ( mean three measurement ) inform consent ocular diseases treatment , cause influence macular oedema , include prior laser photocoagulation . Traction oedema allow . glaucoma medium opacity significantly impair light reflection scan Pregnancy severe heart , lung and/or renal insufficiency ( judged primary investigator )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Macular oedema</keyword>
	<keyword>Osmosis</keyword>
	<keyword>Galactose</keyword>
	<keyword>Intravenous</keyword>
	<keyword>Retinal thickness</keyword>
	<keyword>Starling</keyword>
</DOC>